AtaiBeckley announces CFO transition
Source: SeekingAlpha
2026-02-19 08:59:57 ET
More on ATAI Life Sciences
- AtaiBeckley: A Massive Market Opportunity But Execution Risk Exists
- Psychedelics stocks could benefit from marijuana rescheduling: Jefferies
- Seeking Alpha’s Quant Rating on ATAI Life Sciences
- Historical earnings data for ATAI Life Sciences
- Financial information for ATAI Life Sciences
Read the full article on Seeking Alpha
For further details see:
AtaiBeckley announces CFO transition
ATAI Life Sciences N.V.
NASDAQ: ATAI
ATAI Trading
-4.63% G/L:
$3.505 Last:
2,397,150 Volume:
$3.61 Open:
ATAI Latest News
March 03, 2026 07:00:00 am
AtaiBeckley Announces Successful End-of-Phase 2 Meeting for BPL-003 in Treatment-Resistant Depression
February 27, 2026 11:44:00 am
Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments
ATAI Stock Data
$1,443,705,400
301,295,593
0.1%
45
N/A
Biotechnology & Life Sciences
Healthcare
DE
Amstelveen
